AzTrials
AzTrials

Age-related Hearing Impairment 1HEARSNCT02045511

The Baltimore HEARS Pilot Study

A study testing Baltimore HEARS in people with Age-related Hearing Impairment 1 and Personal Communication, run by Johns Hopkins University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The primary purpose of the study is to develop and test the preliminary efficacy of a first-in-kind community-based intervention to provide affordable, accessible and effective hearing health care to low-income, minority older adults. Read more about this study

Who is it for?
Ages 60 years and olderHealthy volunteers can take part
What is being tested?
Baltimore HEARS
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
15 participants
Where
1 siteUnited States
Study dates
Feb 2014to Sep 2015
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 60 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Age 60 years or older
  • English-speaking
  • Aural-oral verbal communication as primary communication modality
  • Post-lingual hearing loss
  • Does not currently use a hearing amplification device or hearing aid
  • Signed informed consent to participate in baseline, 1 month, and 3 month assessments
  • Have a communication partner able to accompany them to all study-related appointments

Who cannot join

  • Individuals who do not fulfill inclusion criteria
  • Score ≤ 25 on the Montreal Cognitive Assessment

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Weinberg Senior Living Communities

    Baltimore, Maryland, 21215

Other trials in United States

About this study

Official title: The Baltimore HEARS Pilot Study: Hearing Health Care Equality Through Accessible Research & Solutions

The primary purpose of the study is to develop and test the preliminary efficacy of a first-in-kind community-based intervention to provide affordable, accessible and effective hearing health care to low-income, minority older adults.

Read the detailed description

Age-related hearing impairment is strongly associated with poorer communicative functioning and social isolation, but hearing impairment often goes undiagnosed and untreated, particularly among minority and low-income older adults. Novel interventions that translate research on social engagement, minority health, and hearing technology are needed to expand delivery of hearing health care to underserved older adults. The Baltimore Hearing Equality through Accessible Research and Solutions (HEARS) project will develop and pilot a first-in-kind community-based intervention to provide affordable, accessible, and effective hearing health care to minority and low-income older adults and their communication partners. The study will follow a mixed-methods approach that will incorporate quantitative and qualitative components throughout the formative and evaluative processes. Participants and their communication partners will be randomized to an immediate treatment group or a 3-month delayed treatment group. The investigators hypothesize that the intervention is associated with increased social engagement and communication, improved quality of life, and decreased loneliness and third-party disability in the immediate treatment compared to the delayed treatment group.

Being tested
Baltimore HEARS
Medical subject headings
Age-Related Hearing Impairment 1, Communication

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Baltimore HEARSBehavioural

    Tailored aural rehabilitation for participant and communication partner

  • Baltimore HEARSDevice

    Tailored fitting and programming of a personal sound amplifier. This will be accompanied by a component of aural rehabilitation.

Study groups in NCT02045511
Study groupRoleWhat they receive
Immediate Treatment GroupExperimentalImmediate treatment with Baltimore HEARS intervention
Receives: Behavioral: Baltimore HEARS; Device: Baltimore HEARS
Delayed Treatment GroupPlacebo comparator3-month delayed treatment with Baltimore HEARS intervention
Receives: Behavioral: Baltimore HEARS; Device: Baltimore HEARS

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change From Baseline in Hearing Handicap Inventory for the Elderly (HHIE)-S at 3 Months

    Mean change, Unpooled - comparing baseline to 3 month follow-up visit

    Measure Description: Measure was collected through a one-on-one interview with a trained data collector.

    Scoring:

    0-8 suggests no hearing handicap 10-24 suggests mild-moderate hearing handicap 26-40 suggests significant hearing handicap

    Measured: 3 months

Secondary outcomes (5)
  1. Change From Baseline in Revised QDS at 3 Months

    Mean change, Unpooled - comparing baseline to 3 month follow-up visit

    [1] Measure Description: Measure was collected through a one-on-one interview conducted by a trained data collector.

    Survey includes 5 questions, scored Strongly disagree, Slightly disagree, neither, slightly agree, or strongly agree (1, 2, 3, 4, 5)

    Scoring is from 1 (worst) to 5 (best). Scores were summed across each of the 5 survey questions resulting in a total range of 5 (worst) to 25 (best)

    Although utilized in multiple studies, including Yueh et al., 2001, there are no numerical anchors for what would represent a clinically important difference.

    Measured: 3 months

  2. Change From Baseline in Revised UCLA at 3 Months

    Mean change, Unpooled - comparing baseline to 3 month follow-up visit

    [1] Measure Description: Measure was collected via a one-on-one interview conducted by a trained data collector.

    20-item Likert-type scale. Total score is sum of the 20 items, scores range from 20 to 80. Lower values equate to lower levels of loneliness and higher values equate to higher levels of loneliness.

    Perry et al., 1990 uses the following score ranges:

    20-34 - Low degree of loneliness 35-49 - Moderate degree of loneliness 50-64 - Moderately high degree of loneliness 65-80 - High degree of loneliness

    Measured: 3 months

  3. Change From Baseline in PHQ-9 at 3 Months

    Mean change, Unpooled - comparing baseline to 3 month follow-up visit

    [1] Measure Description: Measure collected via one-on-one interview conducted by trained data collectors.

    Total of 9 questions, scored from 0 to 3. The score from each question are summed to a total score, which can range from 0 to 27.

    Interpretation of Total Score Total Score Depression Severity 0 No depression 1-4 Minimal depression 5-9 Mild depression 10-14 Moderate depression 15-19 Moderately severe depression 20-27 Severe depression.

    Change from baseline to 3 months was reported. An increase in the score from baseline to three months (a positive number) indicates a worsening in depression severity. A decrease in the score from baseline to three months (a negative number) indicates a reduction in depression severity.

    Measured: 3 months

  4. Change From Baseline in SF-36 Mental Component at 3 Months

    Mean change, Unpooled - comparing baseline to 3 month follow-up visit

    Data were collected via one-on-one interviews with trained data collectors.

    Standard scoring can be found at http://www.rand.org/health/surveys_tools/mos/36-item-short-form/scoring.html.

    Higher scores indicate better mental health functioning; U.S. population norm: M = 50.0, SD = 10.0, range = [2-74].

    Measured: 3 months

  5. Change From Baseline in SF-36 Physical Component at 3 Months

    Mean change, Unpooled - comparing baseline to 3 month follow-up visit

    Measure collected via one-on-one interview conducted by trained data collectors.

    Standard scoring can be found at http://www.rand.org/health/surveys_tools/mos/36-item-short-form/scoring.html.

    Higher scores indicate better physical health functioning; U.S. population norm: M = 50, SD = 9.95, range = [4-71].

    Measured: 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Jan 2014 (estimated)
  2. Study startFeb 2014
  3. Primary completionSep 2015
  4. Study completionSep 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
15 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02045511
Sponsor's protocol ID
NA_00088278
Acronym
HEARS
Status last verified
Aug 2018
First submitted
22 Jan 2014
Last updated
22 Aug 2018
Data monitoring committee
Yes
Individual data sharing
No

Publications

  • Ventry IM, Weinstein BE. Identification of elderly people with hearing problems. ASHA. 1983 Jul;25(7):37-42. No abstract available.

    PubMed 6626295
  • Weinstein BE. Validity of a screening protocol for identifying elderly people with hearing problems. ASHA. 1986 May;28(5):41-5. No abstract available.

    PubMed 3718608
  • Tuley MR, Mulrow CD, Aguilar C, Velez R. A critical reevaluation of the Quantified Denver Scale of Communication Function. Ear Hear. 1990 Feb;11(1):56-61. doi: 10.1097/00003446-199002000-00011.

    PubMed 2307305
  • Russell D, Peplau LA, Cutrona CE. The revised UCLA Loneliness Scale: concurrent and discriminant validity evidence. J Pers Soc Psychol. 1980 Sep;39(3):472-80. doi: 10.1037//0022-3514.39.3.472.

    PubMed 7431205
  • Stewart AL, Hays RD, Ware JE Jr. The MOS short-form general health survey. Reliability and validity in a patient population. Med Care. 1988 Jul;26(7):724-35. doi: 10.1097/00005650-198807000-00007. No abstract available.

    PubMed 3393032

Questions about this trial

What is this clinical trial studying?

A study testing Baltimore HEARS in people with Age-related Hearing Impairment 1 and Personal Communication, run by Johns Hopkins University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 22 Aug 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 6 Sep 2017). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change From Baseline in Hearing Handicap Inventory for the Elderly (HHIE)-S at 3 Months (time frame: 3 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02045511, which also lists 5 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Aug 2018; AzTrials last refreshed its copy on 27 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in